UPDATE: Ariosa Dx Q1 Revenues Double, Posts Profit | GenomeWeb

The story has been updated to clarify Ariosa's earnings per share for the first quarter of 2014.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics' first quarter revenues more than doubled year over year, the company said in an amended Form S-1 on Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.